Coexistence and Within-Host Evolution of Diversified Lineages of Hypermutable Pseudomonas aeruginosa in Long-term Cystic Fibrosis Infections

PLoS Genetics

Volumn 10, Issue 10, 2014, Pages

  Feliziani, Sofía ^a   Marvig, Rasmus L ^b   Luján, Adela M ^a,c   Moyano, Alejandro J ^a   Di Rienzo, Julio A ^d   Krogh Johansen, Helle ^e   Molin, Søren ^b   Smania, Andrea M ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c UNIVERSITY OF EXETER   (United Kingdom)

^d UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^e University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARGENTINIAN; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIUM ISOLATE; CASE REPORT; CHILD; CLONAL SPECIES; CYSTIC FIBROSIS; DANISH CITIZEN; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; INFECTION CONTROL; MOLECULAR EVOLUTION; MUTATION RATE; MUTATIONAL ANALYSIS; MUTATOR GENE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES COEXISTENCE; SPUTUM CULTURE; YOUNG ADULT; COMPLICATION; CROSS-SECTIONAL STUDY; EVOLUTION; GENETIC VARIATION; GENETICS; LONGITUDINAL STUDY; MICROBIOLOGY; PATHOGENICITY; PENICILLIN RESISTANCE; PSEUDOMONAS INFECTION;

BIOLOGICAL EVOLUTION; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; GENETIC VARIATION; HOST-PATHOGEN INTERACTIONS; HUMANS; LONGITUDINAL STUDIES; METHICILLIN RESISTANCE; MUTATION RATE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84908338190     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004651     Document Type: Article

References (95)

1. Bodey GP, Bolivar R, Fainstein V, Jadeja L, (1983) Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 5: 279–313.
2. Morrison AJ, JrWenzel RP, (1984) Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 6 Suppl 3: S627–642.
3. Govan JR, Deretic V, (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539–574.
4. Lyczak JB, Cannon CL, Pier GB, (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15: 194–222.
5. Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP, (1996) Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 34: 1129–1135.
6. Römling U, Wingender J, Muller H, Tümmler B, (1994) A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 60: 1734–1738.
7. Martin C, Ichou MA, Massicot P, Goudeau A, Quentin R, (1995) Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region. J Clin Microbiol 33: 1461–1466.
8. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, et al. (2011) Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med 183: 1674–1679.
9. Workentine ML, Sibley CD, Glezerson B, Purighalla S, Norgaard-Gron JC, et al. (2013) Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One 8: e60225.
10. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103: 8487–8492.
11. Huse H, Kwon T, Zlosnik J, Speert D, Marcotte E, et al. (2010) Parallel Evolution in Pseudomonas aeruginosa over 39,000 Generations in vivo. MBio 1: e00199–00110.
12. Wong A, Kassen R, (2011) Parallel evolution and local differentiation in quinolone resistance in Pseudomonas aeruginosa. Microbiology 157: 937–944.
13. Oliver A, Cantón R, Campo P, Baquero F, Blázquez J, (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288: 1251–1254.
14. Oliver A, Mena A, (2010) Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin Microbiol Infect 16: 798–808.
15. Oliver A, Baquero F, Blázquez J, (2002) The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 43: 1641–1650.
16. Ciofu O, Riis B, Pressler T, Poulsen HE, Høiby N, (2005) Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 49: 2276–2282.
17. Feliziani S, Luján AM, Moyano AJ, Sola C, Bocco JL, et al. (2010) Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections. PLoS One 5.
18. Marvig RL, Johansen HK, Molin S, Jelsbak L, (2013) Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet 9: e1003741.
19. Waine DJ, Honeybourne D, Smith EG, Whitehouse JL, Dowson CG, (2008) Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa. J Clin Microbiol 46: 3491–3493.
20. Taddei F, Radman M, Maynard-Smith J, Toupance B, Gouyon PH, et al. (1997) Role of mutator alleles in adaptive evolution. Nature 387: 700–702.
21. Cox EC, Gibson TC, (1974) Selection for high mutation rates in chemostats. Genetics 77: 169–184.
22. Sniegowski PD, Gerrish PJ, Lenski RE, (1997) Evolution of high mutation rates in experimental populations of E. coli. Nature 387: 703–705.
23. Mao EF, Lane L, Lee J, Miller JH, (1997) Proliferation of mutators in A cell population. J Bacteriol 179: 417–422.
24. Tenaillon O, Toupance B, Le Nagard H, Taddei F, Godelle B, (1999) Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria. Genetics 152: 485–493.
25. Giraud A, Matic I, Tenaillon O, Clara A, Radman M, et al. (2001) Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291: 2606–2608.
26. Denamur E, Matic I, (2006) Evolution of mutation rates in bacteria. Mol Microbiol 60: 820–827.
27. Oliver A, Levin BR, Juan C, Baquero F, Blázquez J, (2004) Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections. Antimicrob Agents Chemother 48: 4226–4233.
28. Maciá MD, Blanquer D, Togores B, Sauleda J, Pérez JL, et al. (2005) Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 49: 3382–3386.
29. Henrichfreise B, Wiegand I, Pfister W, Wiedemann B, (2007) Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother 51: 4062–4070.
30. Plasencia V, Borrell N, Maciá MD, Moya B, Pérez JL, et al. (2007) Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. Antimicrob Agents Chemother 51: 2574–2581.
31. Ferroni A, Guillemot D, Moumile K, Bernede C, Le Bourgeois M, et al. (2009) Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis. Pediatr Pulmonol 44: 820–825.
32. Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, et al. (2008) Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol 190: 7910–7917.
33. Ciofu O, Mandsberg LF, Bjarnsholt T, Wassermann T, Høiby N, (2010) Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology 156: 1108–1119.
34. Moyano AJ, Luján AM, Argaraña CE, Smania AM, (2007) MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa. Mol Microbiol 64: 547–559.
35. Smania AM, Segura I, Pezza RJ, Becerra C, Albesa I, et al. (2004) Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa. Microbiology 150: 1327–1338.
36. Luján AM, Moyano AJ, Segura I, Argaraña CE, Smania AM, (2007) Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain. Microbiology 153: 225–237.
37. Luján AM, Maciá MD, Yang L, Molin S, Oliver A, et al. (2011) Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators. PLoS One 6: e27842.
38. Moyano AJ, Smania AM, (2009) Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa. PLoS One 4: e8203.
39. Moyano AJ, Feliziani S, Di Rienzo JA, Smania AM, (2013) Simple Sequence Repeats Together with Mismatch Repair Deficiency Can Bias Mutagenic Pathways in Pseudomonas aeruginosa during Chronic Lung Infection. PLoS One 8: e80514.
40. Cramer N, Klockgether J, Wrasman K, Schmidt M, Davenport CF, et al. (2011) Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ Microbiol 13: 1690–1704.
41. Smith EE, Sims EH, Spencer DH, Kaul R, Olson MV, (2005) Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa. J Bacteriol 187: 2138–2147.
42. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, et al. (2011) Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci U S A 108: 7481–7486.
43. Chung JC, Becq J, Fraser L, Schulz-Trieglaff O, Bond NJ, et al. (2012) Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J Bacteriol 194: 4857–4866.
44. Yang L, Haagensen JA, Jelsbak L, Johansen HK, Sternberg C, et al. (2008) In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol 190: 2767–2776.
45. Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, et al. (2007) Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 104: 8101–8106.
46. Drummond AJ, Suchard MA, Xie D, Rambaut A, (2012) Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29: 1969–1973.
47. Godfrey AJ, Bryan LE, Rabin HR, (1981) beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment. Antimicrob Agents Chemother 19: 705–711.
48. Kohler T, Michea-Hamzehpour M, Henze U, Gotoh N, Curty LK, et al. (1997) Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 23: 345–354.
49. Livermore DM, (1995) beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8: 557–584.
50. Mine T, Morita Y, Kataoka A, Mizushima T, Tsuchiya T, (1999) Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob Agents Chemother 43: 415–417.
51. Poole K, (2005) Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49: 479–487.
52. Vettoretti L, Plesiat P, Muller C, El Garch F, Phan G, et al. (2009) Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 53: 1987–1997.
53. Zhang L, Mah TF, (2008) Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 190: 4447–4452.
54. Davies JA, Harrison JJ, Marques LL, Foglia GR, Stremick CA, et al. (2007) The GacS sensor kinase controls phenotypic reversion of small colony variants isolated from biofilms of Pseudomonas aeruginosa PA14. FEMS Microbiol Ecol 59: 32–46.
55. Sall KM, Casabona MG, Bordi C, Huber P, de Bentzmann S, et al. (2014) A gacS Deletion in Pseudomonas aeruginosa Cystic Fibrosis Isolate CHA Shapes Its Virulence. PLoS One 9: e95936.
56. Nelson LK, Stanton MM, Elphinstone RE, Helwerda J, Turner RJ, et al. (2010) Phenotypic diversification in vivo: Pseudomonas aeruginosa gacS- strains generate small colony variants in vivo that are distinct from in vitro variants. Microbiology 156: 3699–3709.
57. Bielecki P, Lukat P, Husecken K, Dotsch A, Steinmetz H, et al. (2012) Mutation in elongation factor G confers resistance to the antibiotic argyrin in the opportunistic pathogen Pseudomonas aeruginosa. Chembiochem 13: 2339–2345.
58. Nyfeler B, Hoepfner D, Palestrant D, Kirby CA, Whitehead L, et al. (2012) Identification of elongation factor G as the conserved cellular target of argyrin B. PLoS One 7: e42657.
59. Overhage J, Schemionek M, Webb JS, Rehm BH, (2005) Expression of the psl operon in Pseudomonas aeruginosa PAO1 biofilms: PslA performs an essential function in biofilm formation. Appl Environ Microbiol 71: 4407–4413.
60. Vallet I, Olson JW, Lory S, Lazdunski A, Filloux A, (2001) The chaperone/usher pathways of Pseudomonas aeruginosa: identification of fimbrial gene clusters (cup) and their involvement in biofilm formation. Proc Natl Acad Sci U S A 98: 6911–6916.
61. Mahenthiralingam E, Campbell ME, Speert DP, (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62: 596–605.
62. D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Déziel E, et al. (2007) Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64: 512–533.
63. Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, et al. (2009) Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros 8: 66–70.
64. Martin DW, Schurr MJ, Mudd MH, Govan JR, Holloway BW, et al. (1993) Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A 90: 8377–8381.
65. Montanari S, Oliver A, Salerno P, Mena A, Bertoni G, et al. (2007) Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis. Microbiology 153: 1445–1454.
66. García-Castillo M, Máiz L, Morosini MI, Rodríguez-Baños M, Suarez L, et al. (2012) Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient. J Clin Microbiol 50: 1777–1778.
67. Wu TH, Marinus MG, (1999) Deletion mutation analysis of the mutS gene in Escherichia coli. J Biol Chem 274: 5948–5952.
68. Miguel V, Monti MR, Argaraña CE, (2008) The role of MutS oligomers on Pseudomonas aeruginosa mismatch repair system activity. DNA Repair (Amst) 7: 1799–1808.
69. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, et al. (2011) Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 39: D596–600.
70. Jelsbak L, Johansen HK, Frost AL, Thogersen R, Thomsen LE, et al. (2007) Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75: 2214–2224.
71. Rau MH, Hansen SK, Johansen HK, Thomsen LE, Workman CT, et al. (2010) Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ Microbiol 12: 1643–1658.
72. Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, et al. (2009) Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res 19: 12–23.
73. Wilder CN, Allada G, Schuster M, (2009) Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect Immun 77: 5631–5639.
74. Turrientes MC, Baquero F, Levin BR, Martínez JL, Ripoll A, et al. (2013) Normal mutation rate variants arise in a Mutator (MutS) Escherichia coli population. PLoS One 8: e72963.
75. Galabert C, Jacquot J, Zahm JM, Puchelle E, (1987) Relationships between the lipid content and the rheological properties of airway secretions in cystic fibrosis. Clin Chim Acta 164: 139–149.
76. Rose MC, Voynow JA, (2006) Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86: 245–278.
77. Barth AL, Pitt TL, (1996) The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 45: 110–119.
78. Rau MH, Marvig RL, Ehrlich GD, Molin S, Jelsbak L, (2012) Deletion and acquisition of genomic content during early stage adaptation of Pseudomonas aeruginosa to a human host environment. Environ Microbiol 14: 2200–2211.
79. Lee DG, Urbach JM, Wu G, Liberati NT, Feinbaum RL, et al. (2006) Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 7: R90.
80. Mareghetti L, Marquet-van der Mee N, Loulergue J, Rolland JC, A A, (1998) Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility. Pathol Biol 46: 319–324.
81. Römling U, Tümmler B, (2000) Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol 38: 464–465.
82. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233–2239.
83. Morales G, Wiehlmann L, Gudowius P, van Delden C, Tümmler B, et al. (2004) Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping. J Bacteriol 186: 4228–4237.
84. Zerbino DR, Birney E, (2008) Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18: 821–829.
85. Krawitz P, Rodelsperger C, Jager M, Jostins L, Bauer S, et al. (2010) Microindel detection in short-read sequence data. Bioinformatics 26: 722–729.
86. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078–2079.
87. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491–498.
88. Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, et al. (2004) Versatile and open software for comparing large genomes. Genome Biol 5: R12.
89. Balzarini MG. DRJA InfoGen versión 2013.FCA, Universidad Nacional de Córdoba, Argentina. URL http://www.info-gen.com.ar.
90. Pezza RJ, Smania AM, Barra JL, Argaraña CE, (2002) Nucleotides and heteroduplex DNA preserve the active conformation of Pseudomonas aeruginosa MutS by preventing protein oligomerization. Biochem J 361: 87–95.
91. Jacquelín DK, Martina MA, Argaraña CE, Barra JL, (2008) Plasmid expression of mutS, -L and/or -H gene in Escherichia coli dam cells results in strains that display reduced mutation frequency. Mutat Res 637: 197–204.
92. Choi KH, Schweizer HP, (2005) An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol 5: 30.
93. Bochner BR, (2009) Global phenotypic characterization of bacteria. FEMS Microbiol Rev 33: 191–205.
94. Bochner BR, (2003) New technologies to assess genotype-phenotype relationships. Nat Rev Genet 4: 309–314.
95. Cooper VS, Lenski RE, (2000) The population genetics of ecological specialization in evolving Escherichia coli populations. Nature 407: 736–739.